Advertisement
U.S. markets open in 6 minutes
S&P Futures
6,032.50 +45.50 (+0.76%) Dow Futures
44,793.00 +398.00 (+0.90%) Nasdaq Futures
21,032.00 +182.25 (+0.87%) Russell 2000 Futures
2,444.20 +30.60 (+1.27%) Crude Oil
69.66 -1.58 (-2.22%) Gold
2,662.10 -50.10 (-1.85%)
At close: 04:00PM EST
Pre-Market:
| Previous Close | 14.00 |
| Open | 14.00 |
| Bid | 13.69 x 100 |
| Ask | 13.89 x 300 |
| Day's Range | 13.48 - 14.34 |
| 52 Week Range | 9.93 - 19.79 |
| Volume | |
| Avg. Volume | 359,557 |
| Market Cap | 797.439M |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | 11.52 |
| EPS (TTM) | 1.20 |
| Earnings Date | Nov 26, 2024 |
| Forward Dividend & Yield | 0.60 (4.34%) |
| Ex-Dividend Date | Aug 27, 2024 |
| 1y Target Est | 16.07 |
Yahoo FinanceInside a $400 billion bet on the brain-computer interface revolution
Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.
GlobeNewswireUPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 26, 2024. Those who would like to participate may access the live webcast here, or
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.